-
HHS Xavier Becerra said the 2022 premium should be adjusted downward, but legal and operational hurdles prevented officials from doing that in the middle of the year.
-
Insurers say prior authorization requirements are intended to reduce wasteful and inappropriate health care spending. But they can baffle patients waiting for approval. And doctors say that insurers have yet to follow through on commitments to improve the process.
-
At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent COVID. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.
-
States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste while people who could benefit get sicker.
-
Under an order from President Biden, the Pentagon is deploying 1,000 troops to help hospitals that are experiencing a surge in patients and have a lot of employees out sick.
-
State Medicaid agencies for months have been preparing for the end of a federal mandate that has prevented states from removing people from the safety-net program during the pandemic.
-
Some consumers "have gone months" without realizing someone had improperly enrolled them in health plans, with tax credits that may need repaying. A proposed new rule would stop the practice.
-
In a letter sent to HHS Secretary Xavier Becerra, Dr. Joseph Ladapo wrote that federal agencies should not be controlling COVID options. He asked that Florida be able to pursue unlimited acquisition of any treatment.
-
The promising antiviral drugs to treat COVID can halt hospitalizations and deaths, but only if they’re given to patients within three to five days of their first symptoms, a narrow window many people won’t meet. Here’s why.
-
Health and Human Services Secretary Xavier Becerra says health providers who have exploited a complicated system to charge exorbitant rates will have to bear their share of the cost — or close.